Five-year clinical follow-up after implantation of the endeavor zotarolimus-eluting stent: ENDEAVOR I, first-in-human study

Catheterization and Cardiovascular Interventions

Volumn 74, Issue 7, 2009, Pages 989-995

  Meredith, Ian T ^a   Ormiston, John ^b,c   Whitbourn, Robert ^d   Kay, I Patrick ^e   Muller, David ^f   Cutlip, Donald E ^g  

^a MONASH UNIVERSITY   (Australia)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

^c Mercy Hospital   (New Zealand)

^d ST VINCENT S HOSPITAL   (Australia)

^e UNIVERSITY OF AUCKLAND   (New Zealand)

^f ST VINCENT S HOSPITAL   (Australia)

^g HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Coronary artery disease; Drug eluting stents; Zotarolimus

Indexed keywords

ACETYLSALICYLIC ACID; ALLOY; CLOPIDOGREL; COBALT; HEPARIN; TICLOPIDINE; ZOTAROLIMUS;

ADULT; ADVERSE OUTCOME; ARTERY DIAMETER; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY RECANALIZATION; DEATH; DRUG ELUTING STENT; FEMALE; HEART INFARCTION; HUMAN; IMPLANTATION; INCIDENCE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LOADING DRUG DOSE; MALE; MULTICENTER STUDY; OUTCOMES RESEARCH; PROSPECTIVE STUDY; RIGHT CORONARY ARTERY; SAFETY; STENT THROMBOSIS; TREATMENT FAILURE; VASCULAR PATENCY;

ADULT; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; AUSTRALIA; CARDIOVASCULAR AGENTS; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MASSACHUSETTS; MIDDLE AGED; MYOCARDIAL INFARCTION; NEW ZEALAND; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; SEVERITY OF ILLNESS INDEX; SIROLIMUS; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 72249101804     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22206     Document Type: Article

References (31)

1. Katritsis DG, Karvouni E, Ioannidis JP. Meta-analysis comparing drug-eluting stents with bare metal stents. Am J Cardiol 2005;95:640-643. (Pubitemid 40255258)
2. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, Colombo A, Schampaert E, Grube E, Kirtane AJ, Cutlip DE, Fahy M, Pocock SJ, Mehran R, Leon MB. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 2007;356:998-1008. (Pubitemid 46376800)
3. Kastrati A, Mehilli J, Pache J, Kaiser C, Valgimigli M, Kelbaek H, Menichelli M, Sabaté M, Suttorp MJ, Baumgart D, Seyfarth M, Pfisterer ME, Schömig A. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007;356:1030-1039. (Pubitemid 46376803)
4. Meredith IT, Ormiston J, Whitbourn R, Kay IP, Muller D, Bonan R, Popma JJ, Cutlip DE, Fitzgerald P, Prpic R, Kuntz RE. First-in-human study of the Endeavor ABT-578-eluting phosphorylcholine-encapsulated stent system in de novo native coronary artery lesions: Endeavor I trial. EuroIntervention 2005;1:157-164.
5. Meredith IT, Ormiston J, Whitbourn R, Kay IP, Muller D, Popma JJ, Cutlip DE, Fitzgerald PJ. Four-year clinical follow-up after implantation of the Endeavor zotarolimus-eluting stent: ENDEAVOR I, the first-in-human study. Am J Cardiol 2007;100[suppl]:56M-61M.
6. Fajadet J, Wijns W, Laarman GJ, Kuck KH, Ormiston J, Münzel T, Popma JJ, Fitzgerald PJ, Bonan R, Kuntz RE. Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial. Circulation 2006;114:798-806. (Pubitemid 44268230)
7. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW, on behalf of the Academic Research Consortium. Academic Research Consortium, Clinical endpoints in coronary stent trials: A case for standardized definitions. Circulation 2007;115:2344-2351.
8. Sketch MH Jr., Ball M, Rutherford B, Popma JJ, Russell C, Kereiakes DJ. Evaluation of the Medtronic (Driver) cobalt-chromium alloy coronary stent system. Am J Cardiol 2005;95:8-12. (Pubitemid 40051104)
9. Whelan DM, van der Giessen WJ, Krabbendam SC, van Vliet EA, Verdouw PD, Serruys PW, van Beusekom HM. Biocompatibility of phosphorylcholine coated stents in normal porcine coronary arteries. Heart 2000;83:338-345.
10. Boland JL, Corbeij HA, Van Der Giessen W, Seabra-Gomes R, Suryapranata H, Wijns W, Hanet C, Suttorp MJ, Buller C, Bonnier JJ, Colombo A, Van Birgelen C, Pieper M, Mangioni JA, Londero H, Carere RG, Hamm CW, Bonan R, Bartorelli A, Kyriakides ZS, Chauhan A, Rothman M, Grinfeld L, Oosterwijk C, Serruys PW, Cumberland DC. Multicenter evaluation of the phosphorylcholine-coated BiodivYsio stent in short de novo coronary lesions: The SOPHOS study. Int J Cardiovasc Interv 2000;3:215-225. (Pubitemid 32064553)
11. Karyekar CS, Pradhan RS, Freeney T, Ji Q, Edeki T, Chiu W, Awni WM, Locke C, Schwartz LB, Granneman RG, O'Dea R. A phase I multiple dose escalation study characterizing pharmacokinetics and safety of ABT- 578 in healthy subjects. J Clin Pharmacol 2005;45:910-918. (Pubitemid 41060230)
12. Braun-Dullaeus RC, Mann MJ, Dzau VJ. Cell cycle progression: new therapeutic target for vascular proliferative disease. Circulation 1998;98:82-89.
13. Marx SO, Marks AR. Bench to bedside: The development of rapamycin and its application to stent restenosis. Circulation 2001;104:852-855.
14. Collingwood R, Gibson L, Sedlik S, Virmani R, Carter AJ. Stent-based delivery of ABT-578 via a phosphorylcholine surface coating reduces neointimal formation in the porcine coronary model. Catheter Cardiovasc Interv 2005;65:227-232. (Pubitemid 40791517)
15. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnàr F, Falotico R. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-1780. (Pubitemid 34586912)
16. Sousa JE, Costa MA, Abizaid A, Abizaid AS, Feres F, Pinto IM, Seixas AC, Staico R, Mattos LA, Sousa AG, Falotico R, Jaeger J, Popma JJ, Serruys PW. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 2001;103:192-195. (Pubitemid 32095401)
17. Sousa JE, Costa MA, Abizaid AC, Rensing BJ, Abizaid AS, Tanajura LF, Kozuma K, Van Langenhove G, Sousa AG, Falotico R, Jaeger J, Popma JJ, Serruys PW. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: One-year angiographic and intravascular ultrasound follow-up. Circulation 2001;104:2007-2011. (Pubitemid 33027038)
18. Grube E, Sonoda S, Ikeno F, Honda Y, Kar S, Chan C, Gerckens U, Lansky AJ, Fitzgerald PJ. Six- and twelve-month results from the first human experience using everolimus-eluting stents with bioabsorbable polymer. Circulation 2004;109:2168-2171. (Pubitemid 38625391)
19. Colombo A, Drzewiecki J, Banning A, Grube E, Hauptmann K, Silber S, Dudek D, Fort S, Schiele F, Zmudka K, Guagliumi G, Russell ME. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 2003;108:788-794. (Pubitemid 37022118)
20. Grube E, Silber S, Hauptmann KE, Mueller R, Buellesfeld L, Gerckens U, Russell ME. TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation 2003;107:38-42. (Pubitemid 36070930)
21. Tanabe K, Serruys PW, Degertekin M, Guagliumi G, Grube E, Chan C, Munzel T, Belardi J, Ruzyllo W, Bilodeau L, Kelbaek H, Ormiston J, Dawkins K, Roy L, Strauss BH, Disco C, Koglin J, Russell ME, Colombo A. Chronic arterial responses to polymer-controlled paclitaxel-eluting stents: Comparison with bare metal stents by serial intravascular ultrasound analyses: data from the randomized TAXUS-II trial. Circulation 2004;109:196-200. (Pubitemid 38114139)
22. Serruys PW, Degertekin M, Tanabe K, Abizaid A, Sousa JE, Colombo A, Guagliumi G, Wijns W, Lindeboom WK, Ligthart J, de Feyter PJ, Morice MC. Intravascular ultrasound findings in the multicenter randomized, double-blind RAVEL (RAdomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial. Circulation 2002;106:798-803.
23. Degertekin M, Serruys PW, Foley DP, Tanabe K, Regar E, Vos J, Smits PC, van der Giessen WJ, van den Brand M, de Feyter P, Popma JJ. Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent-implantation: Long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up. Circulation 2002;106:1610-1613.
24. Bavry AA, Kumbhani DJ, Helton TJ, Borek PP, Mood GR, Bhatt DL. Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials. Am J Med. 2006;119:1056-1061. (Pubitemid 44826931)
25. Pfisterer M, Brunner-La Rocca HP, Buser PT, Rickenbacher P, Hunziker P, Mueller C, Jeger R, Bader F, Osswald S, Kaiser C. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: An observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 2006;48:2584-2591. (Pubitemid 44881238)
26. Lagerqvist B, James SK, Stenestrand S, Lindbäck J, Nilsson T, Wallentin L. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 2007;356:1009-1019. (Pubitemid 46376801)
27. Mauri L, Hsieh W, Massaro JM, Ho K, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007;356:1020-1029. (Pubitemid 46376802)
28. Spaulding C, Daemen J, Boersma E, Cutlip DE, Serruys PW. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007;356:989-997. (Pubitemid 46376799)
29. Smith SC Jr., Feldman TE, Hirshfeld JW Jr., Jacobs AK, Kern MJ, King SB 3rd, Morrison DA, O'Neill WW, Schaff HV, Whitlow PL, Williams DO, Antman EM, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention-summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 2006;113:156-175.
30. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Guidelines for percutaneous coronary interventions. Eur Heart J 2005;26:804-847.
31. Mauri L, Cutlip DE, Leon MB, Kandzari DE, Wijns W, Fajadet J, Massaro JM, Guo W, Meredith IT. Long term safety results from the Endeavor clinical program: Four-year follow-up (abstr). Am J Cardiol 2008;102:8(Suppl 1):124i.